Proximal insulin receptor signaling and IR Insulin exerts its biological effects by binding to its cell-surface receptors, therby activating specific adapter proteins, such us the insulin receptor substrate (IRS) proteins (principally IRS1 and IRS2), Src-homology 2 (SH2) and protein-tyrosine phosphatase 1B (PTP1B), eventually promoting downstream insulin signaling involving glucose homeostasis
In 2023, it appeared that high-net-worth individuals (HNWI), someone with liquid assets of at least $1 million, have collectively entered a state of "hibernation." During the previous prosperous period when opportunities to make money were abundant, everyone was eager to make a quick buck
Oral semaglutide has previously been shown to reduce cardiovascular events in people with type 2 diabetes and pre-existing cardiovascular disease, chronic kidney disease or both in the SOUL trial (McGuire et al, 2025)
SUSTAIN-FORTE established titration up to semaglutide 2 mg as effective for HbA 1c reduction, although it did not study patients also on insulin
